Article
The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid.
Pharmacogenetics and genomics - 1 Mar 2016
Villegas-Martínez Irene, de-Miguel-Elízaga Irene, Carrasco-Torres Rubén, Marras Carlos, Canteras-Jordana Manuel, Yedra-Guzmán Maria J, Martínez-Villanueva Miriam, Tortosa-Conesa Diego, Martín-Fernández Javier
Abstract excerpt
OBJECTIVE: The aim of this study was to determine the possible relationship between the Sp1 polymorphism of gene COL1A1 and bone metabolism disorder in individuals with epilepsy. METHODS: To this end, we carried out an observational cross-sectional study on 64 patients in monotherapy with an antiepileptic drug. The patients were classified on the basis of the presence of the 's' allele of the COL1A1 Sp1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
